ATE481973T1 - Verfahren zur behandlung einer akuten gefässerkrankung - Google Patents
Verfahren zur behandlung einer akuten gefässerkrankungInfo
- Publication number
- ATE481973T1 ATE481973T1 AT07709154T AT07709154T ATE481973T1 AT E481973 T1 ATE481973 T1 AT E481973T1 AT 07709154 T AT07709154 T AT 07709154T AT 07709154 T AT07709154 T AT 07709154T AT E481973 T1 ATE481973 T1 AT E481973T1
- Authority
- AT
- Austria
- Prior art keywords
- mammal
- acute vascular
- vascular disease
- treating acute
- steroid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US75702706P | 2006-01-09 | 2006-01-09 | |
| EP06100159 | 2006-01-09 | ||
| PCT/NL2007/050006 WO2007081206A1 (en) | 2006-01-09 | 2007-01-09 | A method of treating an acute vascular disorder |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE481973T1 true ATE481973T1 (de) | 2010-10-15 |
Family
ID=36100928
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT07709154T ATE481973T1 (de) | 2006-01-09 | 2007-01-09 | Verfahren zur behandlung einer akuten gefässerkrankung |
Country Status (4)
| Country | Link |
|---|---|
| CN (1) | CN101378762A (es) |
| AT (1) | ATE481973T1 (es) |
| DE (1) | DE602007009358D1 (es) |
| ES (1) | ES2352547T3 (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GEP20217243B (en) | 2015-06-18 | 2021-04-26 | Sprl Estetra | Orodispersible dosage unit containing an estetrol component |
| NO3106148T3 (es) * | 2015-06-18 | 2018-08-11 | ||
| KR20220144885A (ko) | 2016-08-05 | 2022-10-27 | 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 | 월경통 및 생리통의 관리방법 |
| TWI801561B (zh) | 2018-04-19 | 2023-05-11 | 比利時商依思特拉私人有限責任公司 | 化合物及其用於緩解絕經相關症狀的用途 |
-
2007
- 2007-01-09 AT AT07709154T patent/ATE481973T1/de not_active IP Right Cessation
- 2007-01-09 CN CNA2007800045937A patent/CN101378762A/zh active Pending
- 2007-01-09 DE DE602007009358T patent/DE602007009358D1/de active Active
- 2007-01-09 ES ES07709154T patent/ES2352547T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN101378762A (zh) | 2009-03-04 |
| DE602007009358D1 (de) | 2010-11-04 |
| ES2352547T3 (es) | 2011-02-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE534377T1 (de) | Verfahren und zusammensetzungen zur behandlung von hämatologischen erkrankungen | |
| ATE340580T1 (de) | Verwendung von zusammensetzungen enthaltend ein oestrogen zur behandlung und verhinderung von muskelskelettschmerzen | |
| DE602008001783D1 (de) | Verfahren zur behandlung oder prävention von unfruchtbarkeit bei weiblichen säugern und pharmazeutisches kit zur anwendung dieses verfahrens | |
| DK1446128T3 (da) | Anvendelse af östrogenforbindelser i kombination med progestogenforbindelser i hormonsubstitutionsbehandling | |
| TW200740773A (en) | Diaminopyrimidines as P2X3 and P2X2/3 modulators | |
| MX2009008439A (es) | Nuevos inhibidores de la replicacion del virus de hepatitis c. | |
| MX2009003821A (es) | Compuestos de n-aril pirazol para usarse contra la diabetes. | |
| TN2009000012A1 (en) | Amino-piperidine derivatives as cetp inhibitors | |
| ATE536349T1 (de) | In der 2-stellung durch phenyl substituierte 1h- benzimidazol-4-carbonsäureamide sind wirksame parp-inhibitoren | |
| ECSP099330A (es) | Compuesto de indol | |
| HRP20090078A2 (en) | Novel pyridazine compound and use thereof | |
| EA200971026A1 (ru) | Новые макроциклические ингибиторы репликации вируса гепатита с | |
| MX2007008555A (es) | Amino-imidazolonas para la inhibicion de (-secretasa. | |
| NO20085385L (no) | Tiazolforbindelser som cannabinoidreseptorligander og anvendelser derav | |
| BR112012009214A2 (pt) | compostos | |
| MX2009000657A (es) | Composiciones y metodos para el tratamiento de mucositis. | |
| ATE533489T1 (de) | Behandlung von multiplem myelom | |
| BRPI0511569A (pt) | composições e métodos para o tratamento de distúrbio disfórico pré-menstrual | |
| MX2009011205A (es) | Derivados de 2-iminoisotiazol como ligandos del receptor canabinoide. | |
| CY1105883T1 (el) | Μεθοδος θepαπειας ή προληψης διαταραχων οπου μεσολαβει το ανοσοποιητικο και φαρμακευτικο παρασκευασμα για χρηση σε αυτη | |
| ATE522532T1 (de) | Verbindungen zur behandlung von hepatitis c | |
| ATE551343T1 (de) | Tetracyclische verbindungen zur behandlung von hepatitis c | |
| ATE494291T1 (de) | Verbindungen zur behandlung von hepatitis c | |
| EA201170795A1 (ru) | Антагонисты ccr2 группы 4-азетидинил-1-гетероарил-циклогексанола | |
| ATE481973T1 (de) | Verfahren zur behandlung einer akuten gefässerkrankung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |